Proteomic characterization of Aspergillus fumigatus treated with an antifungal coumarin for identification of novel target molecules of key pathways

Journal of Proteome Research

Volumn 11, Issue 6, 2012, Pages 3259-3268

  Singh, Seema ^a,c   Gupta, Shilpi ^b   Singh, Bharat ^a,d   Sharma, Sunil K ^b   Gupta, Vijay K ^d   Sharma, Gainda L ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b UNIVERSITY OF DELHI   (India)

^c UNIVERSITY OF PUNE   (India)

^d KURUKSHETRA UNIVERSITY   (India)

Author keywords

antifungal; Aspergillus f umigatus; coumarin; molecular targets; proteome; therapy

Indexed keywords

ANTIOXIDANT; CELL DIVISION CONTROL PROTEIN; COUMARIN; FUNGAL PROTEIN; PROTEOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RIBOFLAVIN; UBIQUITIN; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE GLUCOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; ANTIFUNGAL AGENT; COUMARIN DERIVATIVE; N,N,N-TRIETHYL-11-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-11-OXOUNDECAN-1-AMINIUM; QUATERNARY AMMONIUM DERIVATIVE;

ANTIFUNGAL ACTIVITY; ASPERGILLUS FUMIGATUS; ATTENUATION; CELL DIVISION; CELL MEMBRANE; CELL WALL; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; ENZYME INHIBITION; MOLECULARLY TARGETED THERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN SYNTHESIS; PROTEOMICS; REVIEW; ASPERGILLOSIS; DRUG EFFECTS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ASPERGILLUS; ASPERGILLUS FUMIGATUS;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; COUMARINS; FUNGAL PROTEINS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TARGETED THERAPY; PROTEIN INTERACTION MAPS; PROTEIN TRANSPORT; PROTEOME; PROTEOMICS; QUATERNARY AMMONIUM COMPOUNDS;

EID: 84861801730     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300006j     Document Type: Review

References (57)

1. Abad, A.; Fernández-Molina, J. V.; Bikandi, J.; Ramí rez, A.; Margareto, J.; Sendino, J.; Hernando, F. L.; Pontó n, J.; Garaizar, J.; Rementeria, A. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis Rev. Iberoam. Micol. 2010, 27, 155-182
2. Agarwal, R. Allergic bronchopulmonary Aspergillosis Chest 2009, 135, 805-826
3. Hu, W.; Sillaots, S.; Lemieux, S.; Davidson, J.; Kauffman, S.; Breton, A.; Linteau, A. Essential gene identification and drug target prioritization in Aspergillus fumigatus PLoS Path. 2007, 3, 0001-0015
4. Baginski, M.; Sternal, K.; Czub, J.; Borowski, E. Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic Acta Biochim. Pol. 2005, 52, 655-658
5. Odds, F. C.; Brown, A. J.; Gow, N. A. Antifungal agents: mechanisms of action Trends Microbiol. 2003, 11, 272-279
6. Johnson, M. D. Use of antifungal combination therapy: agents, order, and timing Curr. Fungal Infect. Rep. 2010, 4, 87-95
7. Steinbach, W. J.; Singh, N.; Miller, J. L.; Benjamin, D. K.; Schell, W. A.; Heitman, J.; Perfect, J. R. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients Antimicrob. Agents Chemother. 2004, 48, 4922-4925
8. Schobel, F.; Jacobsen, I. D.; Brock, M. Evaluation of lysine biosynthesis as an antifungal drug target: biochemical characterization of Aspergillus fumigatus homocitrate synthase and virulence studies Eukaryotic Cell 2010, 9, 878-893
9. Latge, J. P. Aspergillus fumigatus and aspergillosis Clin. Microbiol. Rev. 1999, 12, 310-350
10. Steinbach, W. S.; Latge, J. P.; Stevens, D. A. Advances against aspergillosis Med. Mycol. 2005, 43, S1
11. Kostova, I. Synthetic and natural coumarins as cytotoxic agents Curr. Med. Chem. - Anti-Cancer Agents 2005, 5, 29-46
12. Yang, J.; Liu, G.; Dai, F.; Cao, X.; Kang, Y.; Hu, L.; Tang, J.; Li, X.; Li, Y.; Jin, X.; Zhou, B. Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents Antimicrob. Agents Chemother. 2011, 21, 6420-6425
13. Cardoso, S. H.; Barreto, M. B.; Lourenco, M. C. S.; de O. Henriques, M. G.; Candea, A. L. P.; Kaiser, C. R.; De Souza, M. V. N. Antitubercular activity of new coumarins Chem. Biol. Drug. Des. 2011, 77, 489-493
14. Lee, S.; Sivakumar, K.; Shin, W.; Xiea, F.; Wang, Q. Synthesis and anti-angiogenesis activity of coumarin derivatives Bioor. Med. Chem. Lett. 2006, 16, 4596-4599
15. Montagner, C.; de Souza, S. M.; Groposo, C.; Monache, F. D.; Smania, E. F. A.; Smania, A., Jr. Antifungal activity of coumarins Z. Naturforsch. 2008, 63, 21-28
16. Stein, A. C.; Alvarez, S.; Avancini, C.; Zacchino, S.; Von Poser, G. Antifungal activity of some coumarins obtained from species of Pterocaulon (Asteraceae) J. Ethnopharmacol. 2006, 107, 95-98
17. Vodisch, M.; Scherlach, K.; Winkler, R.; Hertweck, C.; Braun, H. Analysis of the Aspergillus fumigatus proteome reveals metabolic changes and the activation of the Pseurotin A biosynthesis gene J. Prot. Res. 2011, 10, 2508-2524
18. Gautam, P.; Shankar, J.; Madan, T.; Sirdeshmukh, R.; Sundaram, C. S.; Gade, W. N.; Basir, S. F.; Sarma, P. U. Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to Amphotericin B Antimicrob. Agents Chemother. 2008, 52, 4220-4227
19. Cagas, S. E.; Jain, M. R.; Li, H.; Perlin, D. S. Profiling the Aspergillus fumigatus proteome in response to caspofungin Antimicrob. Agents Chemother. 2011, 55, 146-154
20. Gupta, S.; Singh, S.; Kathuria, A.; Kumar, M.; Sharma, S.; Kumar, R.; Parmar, V. S.; Singh, B.; Gupta, A.; Eycken, E. V. D.; Sharma, G. L.; Sharma, S. K. Ammonium derivatives of chromenones and quinolinones as lead antimicrobial agents J. Chem. Sci. 2012, 124, 437-449
21. Dabur, R.; Chhillar, A. K.; Yadav, V.; Kamal, P. K.; Gupta, J.; Sharma, G. L. In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2), a dihydropyrrole derivative J. Med. Microbiol. 2005, 54, 549-552
22. Chhillar, A. K.; Arya, P.; Mukherjee, C.; Kumar, P.; Yadav, Y.; Sharma, A. K.; Yadav, V.; Gupta, J.; Dabur, R.; Jha, H. N.; Watterson, A. C.; Parmar, V. S.; Prasad, A. K.; Sharma, G. L. Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: novel compounds against aspergillosis Bioorg. Med. Chem. 2006, 14, 973-981
23. Chhillar, A. K.; Yadav, V.; Kumar, A.; Kumar, M.; Parmar, V. S.; Prasad, A.; Sharma, G. L. Differential expression of Aspergillus fumigatus protein in response to treatment with a novel antifungal compound, diethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarboxylate Mycoses 2008, 52, 223-227
24. Singh, B.; Sharma, G. L.; Oellerich, M.; Kumar, R.; Singh, S.; Bhadoria, D. P.; Katyal, A.; Reichard, U.; Asif, A. R. Novel cytosolic allergens of Aspergillus fumigatus identified from germinating conidia J. Prot. Res. 2010, 9, 5530-5541
25. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-254
26. Blum, H.; Beier, H.; Gross, H. J. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels Electrophoresis 1987, 8, 93-99
27. Owen, J. B.; Di Domenico, F.; Sultana, R.; Perluigi, M.; Cini, C.; Pierce, W. M.; Butterfield, D. A. Proteomics-determined differences in the Concanavalin-A fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: Implications for progression of AD J. Prot. Res. 2009, 8, 471-482
28. Qasim, M.; Rahman, H.; Oellerich, M.; Asif, A. R. Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment. Proteome Sci. 2011, Sep 20, 9, 57.
29. Von Mering, C.; Jensen, L. J.; Snel, B.; Hooper, S. D.; Krupp, M.; Foglierini, M.; Jouffre, N.; Huynen, M. A.; Bork, P. STRING: known and predicted protein- protein associations, integrated and transferred across organisms Nucleic Acids Res. 2005, 33, 433-437
30. Cline, M. S.; Smoot, M.; Cerami, E.; Kuchinsky, A.; Landys, N.; Workman, C.; Christmas, R.; Avila-Campilo, I.; Creech, M.; Gross, B.; Hanspers, K.; Isserlin, R.; Kelley, R.; Killcoyne, S.; Lotia, S.; Maere, S.; Morris, J.; Ono, K.; Pavlovic, V.; Pico, A. R.; Vailaya, A.; Wang, P. L.; Adler, A.; Conklin, B. R.; Hood, L.; Kuiper, M.; Sander, C.; Schmulevich, I.; Schwikowski, B.; Warner, G. J.; Ideker, T.; Bader, G. D. Integration of biological networks and gene expression data using cytoscape Nat. Protoc. 2007, 2, 2366-2382
31. Vodisch, M.; Albrecht, D.; Leßing, F.; Schmidt, A. D.; Winkler, R.; Guthke, R.; Brakhage, A. A.; Kniemeyer, O. Two-dimensional proteome reference maps for the human pathogenic filamentous fungus Aspergillus fumigatus Proteomics 2009, 9, 1407-1415
32. Hoehamer, C. F.; Cummings, E. D.; Hilliard, G. M.; Rogers, P. D. Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents Antimicrob. Agents Chemother. 2010, 54, 1655-1664
33. Bruneau, J. M.; Maillet, I.; Tagat, E.; Legrand, R.; Supatto, F.; Fudali, C.; Caer, J. P.; Labas, V.; Lecaque, D.; Hodgson, J. Drug induced proteome changes in Candida albicans: comparison of the effect of beta (1,3) glucan synthase inhibitors and two triazoles, fluconazole and itraconazole Proteomics 2003, 3, 325-336
34. Peterson, S. W. Neosartorya pseudofischeri sp. nov. and its relationship to other species in Aspergillus section Fumigati Mycol. Res. 1992, 96, 547-554
35. Cagas, S. E.; Jain, M.; Li, H.; Perlin, D. S. The proteomic signature of Aspergillus fumigatus during early development Mol. Cell Proteomics 2011, 10, M111.010108
36. Singh, B.; Oellerich, M.; Kumar, R.; Kumar, M.; Bhadoria, D. P.; Reichard, U.; Sharma, G. L.; Asif, A. R. Immuno-Reactive molecules identified from the secreted proteome of Aspergillus fumigatus J. Prot. Res. 2010, 9, 5517-5529
37. Yang, Y.; Kitagaki, J.; Dai, R. M.; Tsai, Y. C.; Lorick, K. L.; Ludwig, R. L.; Pierre, S. A.; Jensen, J. P.; Davydov, I. V.; Oberoi, P.; Li, C. C.; Kenten, J. H.; Beutler, J. A.; Vousden, K. H.; Weissman, A. M. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics Cancer Res. 2007, 67, 9472-9481
38. Okoli, I.; Coleman, J. J.; Tempakakis, E.; An, W. F.; Ausubel, F. M.; Mylonakis, E. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay PLoS One 2009, 4, 1-8
39. Thoden, J. B.; Holden, H. M. The molecular architecture of glucose-1-phosphate uridylyltransferase Protein Sci. 2007, 16, 432-440
40. Paunesku, T.; Mittal, S.; Protić , M.; Oryhon, J.; Korolev, S. V.; Joachimiak, A.; Woloschak, G. E. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome Int. J. Radiat. Biol. 2001, 77, 1007-1021
41. Robinson, A.; Brzoska, A. J.; Turner, K. M.; Withers, R.; Harry, E. J.; Lewis, P. J.; Dixon, N. E. Essential biological processes of an emerging pathogen: DNA replication, transcription, and cell division in Acinetobacter spp Microbiol. Mol. Biol. Rev. 2010, 74, 273-297
42. Kin, L. S.; Kim, J. H. Heat shock protein as molecular targets for breast cancer therapeutics J. Breast Cancer 2011, 14, 167-174
43. Voos, W.; Rottgers, K. Molecular chaperones as essential mediators of mitochondrial biogenesis Biochim. Biophys. Acta 2002, 1592, 51-62
44. Hondorp, E. R.; Matthews, R. G. Oxidative stress inactivates cobalamin-independent methionine synthase (MetE) in Escherichia coli PLoS Biol. 2004, 2, 1738-1753
45. Pascon, R. C.; Ganous, T. M.; Kngsbury, J. M.; Cox, G. M.; McCusker, J. H. Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence Microbiology 2004, 150, 3013-3023
46. Schmidt, A.; Wu, H.; Mackenzie, R. E.; Chen, V. J.; Bewly, J. R.; Ray, J. E.; Toth, J. E.; Cygler, M. Structures of three inhibitor complexes provide insight into the reaction mechanism of the human methylenetetrahydrofolate dehydrogenase/cyclohydrolase Biochemistry 2000, 39, 6325-6335
47. Park, J.; Gupta, R. S. Adenosine kinase and ribokinase - the RK family of proteins Cell. Mol. Life Sci. 2008, 65, 2875-2896
48. Long, Q.; Ji, L.; Wang, H.; Xie, J. Riboflavin biosynthetic and regulatory factors as potential novel anti-infective drug targets Chem. Biol. Drug Des. 2010, 75, 339-347
49. Kaiser, J.; Illarionov, B.; Rohdich, F.; Eisenreich, W.; Saller, S.; den Brulle, J. V.; Cushman, M.; Bacher, A.; Fischer, M. A high-throughput screening platform for inhibitors of the riboflavin biosynthesis pathway Anal. Biochem. 2007, 365, 52-61
50. Carman, A. J.; Vylkova, S.; Lorenz, M. C. Role of Acetyl Coenzyme A Synthesis and breakdown in alternative carbon source utilization in Candida albicans Eukaryotic Cell 2008, 7, 1733-1741
51. Lee, F. S.; Lin, L.; Smith, J. A. A glucose repressible gene encodes acetyl-CoA hydrolase from Saccharomyces Cerevisae J. Biol. Chem. 1990, 265, 7413-7418
52. Kalmar, B.; Greensmith, L. Induction of heat shock proteins for protection against oxidative stress Adv. Drug Delivery Rev. 2009, 61, 310-318
53. Krappmann, S.; Braus, G. H. Nitrogen metabolism of Aspergillus and its role in pathogenicity Med. Mycol. Suppl. 2005, 43, S31-S40
54. Mizushima, N.; Levine, B.; Cuervo, A. M.; Klionsky, D. J. Autophagy fights disease through cellular self-digestion Nature 2008, 451, 1069-1075
55. Palecek, S. P.; Parikh, A. S.; Kron, S. J. Genetic analysis reveals that FLO11 upregulation and cell polarization independently regulate invasive growth in Saccharomyces cerevisiae Genetics 2000, 156, 1005-1023
56. Schwartz, A. S.; Yu, J.; Gardenour, K. R.; Finley, R. L., Jr.; Ideker, T. Cost-effective strategies for completing the interactome Nat. Methods 2009, 6, 55-61
57. McClellan, A. J.; Xia, Y.; Deutschbauer, A. M.; Davis, R. W.; Gerstein, M.; Frydman, J. Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches Cell 2007, 131, 121-135